Pantheon Awardees 2015
Life Sciences Leadership Awards
Co-Founder and Chairman of the Board, Receptos, Inc.Bill focuses on making and growing investments in biotechnology. He serves as chairman for each of four San Diego companies: Illumina (ILMN, NASDAQ); Neurocrine Biosciences (NBIX, NASDAQ); Receptos (RCPT, NASDAQ) and Fate Therapeutics (FATE, NASDAQ). He also serves as the lead outside director for Cerulean Pharma (CERU, NASDAQ), as well as serving on the board of directors of Regulus Therapeutics (RGLS, NASDAQ), as an advisor to Leerink Partners, a healthcare focused investment bank, and on the Board of Trustees for Caltech.Bill retired at the end of 2005 from Biogen Idec (now Biogen) where he was most recently executive chairman. He joined Idec Pharmaceuticals at its founding in 1986 and grew it to a multi-billion-dollar market valuation company, while serving as chairman and CEO. While at Idec, Bill was a co-inventor of Rituxan® that became the first monoclonal antibody approved by the U.S. FDA for cancer; it went on to become one of the world’s most valuable cancer therapies. Prior to Idec, he served in various capacities at Genentech. Adding to his corporate background, Bill held various faculty positions at MIT, won the award for “Excellence in the Teaching of Chemistry” at Harvard, and is an Alfred P. Sloan Fellow. Bill also practices fine art photography, and most recently is represented by The Madison Gallery in La Jolla. His work also can be seen at www.billrastetter.com.
Associate Director, QB3, Managing Director,
Mission Bay Capital, General Partner, QB3 Incubator PartnersDouglas Crawford’s goal is to help entrepreneurial scientists create successful startups to meet California’s needs for better health, a sustainable environment, and economic growth—particularly jobs. To this end, Crawford and his colleagues have systematically lowered the barriers between great ideas and successful companies. For instance, Crawford created and manages the first incubator within the University of California, the QB3 Garage@UCSF. The QB3 incubator program has now grown to five sites and 62 companies, and he has created a partnership to build a new 24,000 square foot life-science incubator in Mission Bay. More recently, QB3 created a program to help entrepreneurs create companies to pursue government grants and private funding. In the first 23 months this program has helped launch 146 companies, 31 of which are already operational. Crawford is also a founder and managing director of Mission Bay Capital, an $11.3M seed-stage venture fund that makes pivotal early-stage investments in bioscience companies. He is a board member of Atreca (observer), Circle Pharma, Delpor, Magnamosis, Magnap, Ocular Dynamics, and Zephyrus. Crawford received his PhD in biochemistry from UCSF.
Director, The California Institute for Quantitative Biosciences (QB3)
University of CaliforniaDr. Regis B. Kelly is currently executive director of QB3, a University of California Institute created by the legislature to help grow the California economy using research in biology and the life science industries. From 2000 to 2004, Dr. Kelly served as executive vice-chancellor at UCSF, where his major responsibility was the move to the new Mission Bay campus.From 1995 to 2000, Dr. Kelly served as chair of the Department of Biochemistry and Biophysics at UCSF; from 1988 to 1995, he was director of UCSF’s Cell Biology Graduate Program; and from 1992 to 2000, he was director of the Hormone Research Institute at UCSF. Prior to his faculty appointment at UCSF he received postdoctoral training at Harvard and Stanford, graduate training at Caltech and received an undergraduate degree in physics from Edinburgh University. He has published extensively in the areas of cell biology and neurobiology.He is a faculty member in the Department of Biochemistry and Biophysics at UCSF, where he holds the Byers Family Distinguished Professorship. He is chairman emeritus of the Bay Area Scientific Innovation Consortium (BASIC), serves on the Malaysian Prime Minister’s Biotechnology Advisory Panel, and is on the board of the California Foundation for Molecular Biology and KAIST. He is also a general partner of the venture fund Mission Bay Capital and of QB3 Incubator Management, LLC, an entrepreneurship workspace. Dr. Kelly was inducted into the American Academy for Arts and Sciences and into the Bay Area Business Hall of Fame. He also has received the Biomedical Research Leadership Award from the California Society for Biomedical Science and the Salute to Excellence Award from the American Liver Foundation.In December 2013, Dr. Kelly was appointed an Officer of the Most Excellent Order of the British Empire (OBE), “for services to science, innovation and global health.” He was given a Lifetime CEO Award in 2015 from the San Francisco Business Times. In December of 2014 he was made Senior Advisor on Innovation and Entrepreneurship to the President of the University of California.
Biotechnology Educator Award
Bayer Executive Director of the Institute for STEM Education
and Interim Associate Vice President, Research and Professional DevelopmentCalifornia State University, East BayDr. Stephanie Couch is the Bayer Executive Director of the Institute for STEM Education and the interim Associate Vice President for Research at California State University, East Bay. The Institute’s major areas of focus include new approaches to STEM teaching and learning, preparation of future math and science teachers, supporting educators in the field, and student support systems that interest, engage, prepare and retain students in STEM college and career pathways. Couch directs the Gateways East Bay STEM Network, where she engages a diverse array of community stakeholders in efforts to address challenges all along the P20 “cradle to career” education continuum.
Couch’s career has been dedicated to K-12 and higher education policy issues, with an emphasis on issues pertaining to students from disadvantaged backgrounds, school finance, and education technology. She served as an education advisor for two Speakers of the California State Assembly, the Senate Appropriations Committee, and worked as a legislative advocate in Sacramento, specializing in education issues.
Dr. Couch received her B.A. in Political Science from the University of California, Davis, and her M.A. and Ph.D. in Education from the University of California, Santa Barbara.